Raynes-Greenow Camille, Polis Suzanne, Elliott Elizabeth, Hardikar Winita, Kesson Alison, Kaldor John, Jones Cheryl A
Discipline of Paediatrics and Child Health, The University of Sydney, Sydney, New South Wales, Australia.
The Kirby Institute, UNSW Australia, Sydney, New South Wales, Australia.
J Paediatr Child Health. 2015 Nov;51(11):1115-20. doi: 10.1111/jpc.12904. Epub 2015 May 4.
An estimated 1.1% of Australian adults are infected with hepatitis C virus (HCV). Many develop chronic liver disease, and some develop liver failure or hepatocellular carcinoma. HCV infection in Australian children is poorly defined. We aimed to determine the reported incidence, clinical and epidemiological features of newly diagnosed HCV infection in Australian children presenting to paediatricians.
We undertook prospective active national surveillance, using the Australian Paediatric Surveillance Unit, of incident HCV cases in children aged <15 years between 1(st) January 2003, and 31(st) December 2007.
There were 45 confirmed cases of newly diagnosed HCV infection over five years (<1 per 100,000 children aged <15 years per year). Median age at diagnosis was 2.9 years. Positive maternal HCV serostatus was the most frequent reported risk factor for HCV infection in children (40/45). Three children (all aged > 14), were exposed through their own IV drug use. No children were co-infected with HIV and only one child was co-infected with HBV. All children were asymptomatic at diagnosis, although many had minor elevations in liver transaminases. Many clinicians reported difficulties with follow-up.
Childhood HCV infection is uncommon in Australia, although our data likely underestimate the incidence. Only a small number of children aged <18 months was identified, despite known perinatal exposure. Opportunistic investigation of children at risk for HCV, improved education regarding vertical transmission for health care providers, and increased coordination of childhood HCV services are required to improve recognition and management of children with HCV.
据估计,1.1%的澳大利亚成年人感染了丙型肝炎病毒(HCV)。许多人会发展为慢性肝病,有些人会发展为肝衰竭或肝细胞癌。澳大利亚儿童的HCV感染情况尚不明确。我们旨在确定向儿科医生就诊的澳大利亚儿童中新诊断出的HCV感染的报告发病率、临床和流行病学特征。
我们利用澳大利亚儿科监测部门,对2003年1月1日至2007年12月31日期间15岁以下儿童的HCV发病病例进行了前瞻性主动全国监测。
五年间有45例新诊断出的HCV感染确诊病例(每年每10万名15岁以下儿童中不到1例)。诊断时的中位年龄为2.9岁。母亲HCV血清学阳性是报告的儿童HCV感染最常见的危险因素(40/45)。三名儿童(均超过14岁)因自身注射毒品而感染。没有儿童合并感染HIV,只有一名儿童合并感染HBV。所有儿童在诊断时均无症状,尽管许多儿童的肝转氨酶有轻微升高。许多临床医生报告随访存在困难。
儿童HCV感染在澳大利亚并不常见,尽管我们的数据可能低估了发病率。尽管已知有围产期暴露情况,但仅发现少数18个月以下的儿童。需要对有HCV感染风险的儿童进行机会性调查,加强对医护人员关于垂直传播的教育,并加强儿童HCV服务的协调,以提高对HCV感染儿童的识别和管理。